Results

Total Results: 1,134 records

Showing results for "days".

141. Abnormal-Uterine-Bleeding Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/abnormal-uterine-bleeding_executive.pdf
     March 01, 2013 - menses within a 24- to 38-day window • Regularity (i.e., cycle-to-cycle variation) within 2 to 20 days … • Duration of flow from 4 to 8 days • Blood loss volume from 5 to 80 ml Symptoms outside this normal … mefenamic acid, naproxen, meclofenamate, and flurbiprofen given at the onset of menses for up to 5 days … for improving heavy bleeding.29,34,40,47-50 TXA at a dose of 1.95 to 4.5 grams per day for 4 to 5 days … fMean days to ovulation. gCompared with metformin (n=20) or metformin plus exenatide (n=20).

142. Preterm-Birth-Terbutaline-Pump Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/preterm-birth-terbutaline-pump_surveillance.pdf
     January 30, 2013 - various gestational ages (<28 weeks, < 32 weeks, <34 weeks, <37 weeks), mean prolongation of pregnancy (days … gestational ages (<28  weeks, < 32 weeks, <34 weeks, <37 weeks), mean prolongation of pregnancy (days … Matria-based cohort study, more women in the SQ terbutaline pump group had pregnancy prolonged > 7 days … www.effectivehealthcare.ahrq.gov Published online: January 30, 2013 19   for prolongation > 14 days … Matria-based cohort study, more women in the SQ terbutaline pump group had pregnancy prolonged > 7 days

143. Preterm-Birth-Terbutaline-Pump Surveillance (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/preterm-birth-terbutaline-pump_surveillance.pdf
     January 30, 2013 - various gestational ages (<28 weeks, < 32 weeks, <34 weeks, <37 weeks), mean prolongation of pregnancy (days … gestational ages (<28  weeks, < 32 weeks, <34 weeks, <37 weeks), mean prolongation of pregnancy (days … Matria-based cohort study, more women in the SQ terbutaline pump group had pregnancy prolonged > 7 days … www.effectivehealthcare.ahrq.gov Published online: January 30, 2013 19   for prolongation > 14 days … Matria-based cohort study, more women in the SQ terbutaline pump group had pregnancy prolonged > 7 days

144. Blood-Clots-Hip-Knee-Surgery Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/blood-clots-hip-knee-surgery_executive.pdf
     March 01, 2012 - or 3 longer compared with thromboprophylaxis for 7 to 10 days on symptomatic objectively confirmed … for 7 to 10 days in patients who had major orthopedic surgery. … 0–1 and a RR 3.41 (0.77 to 15.18) for major bleeding on days 2–8. … a RR 0.87 (0.37 to 2.06) on days 2–8. … or longer) versus using only short-term prophylaxis (7 to 10 days).

145. Arcia-notes-Teresa (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/arcia-presentation.pdf
     May 29, 2025 - But they could not tell  me how many days per week she exercised, which   I found   kind  of … “Out of the last 30 days, were you  sad, blue or depressed?” … if we had  a graphic that had   five days noted  on   the calendar, people would  say, "Oh

146. Systematic Review on Treatments for Acute Pain: Surveillance Report 2 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/main-apps-surv-report-2-acute-pain.pdf
     May 01, 2022 - weeks: No differences (SOE: low, based on 1 RCT) One RCT (n=100) found continuous cooling for 7 days … Tapentadol vs oxycodone for postoperative pain treatment the first 7 days after total knee arthroplasty … The effect of crizanlizumab on the number of days requiring opioid use for management of pain associated

147. Cer-235-Pharma-Nonpharm-Ptsd-Update-Appendix-G-1 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-235-pharma-nonpharm-ptsd-update-appendix-g-1.xlsx
     May 29, 2025 - Computer-generated random numbers, random numbers table, coin toss No: • Alternation, case record #, birth days … , week days • Participant/provider choice, coverage, ability to pay Unclear: • Reports as “randomized

148. App-F2-Surv-Report-2-Nonopioid-Pharmacol-Chronic-Pain (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f2-surv-report-2-nonopioid-pharmacol-chronic-pain.xlsx
     May 29, 2025 - TCA_PCT Table F-2a. Harms of tricyclic antidepressants versus placebo Author, Year Quality Pain Population Drug Class Drug Assessment Time (Wk) Time Category WAE: n WAE: N SAE: n SAE: N Cardiac Rhythm Abnormalities: Specific AE Cardiac Rhythm Abnormalities: n Cardiac Rhythm Abnormalities: N N Randomized Cognitive Eff…

149. PEPTIC ULCER #11 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/peptic-ulcer-horizon-scan-high-impact-1406.pdf
     June 01, 2014 - and 52% of the 0.10-mg/kg/d dose group had a ≥20% reduction in PN, with a reduction of 1 or more days … After 24 weeks of treatment, 54% of patients treated with teduglutide reduced the number of infusion days … per week by 1 or more days, compared with 23% of patients treated with placebo experiencing such … Additionally, after 12 months of teduglutide treatment, 53% of patients reduced their infusion days … per week and 24% of patients reduced their infusion days per week by 3 or more days.

150. DEcIDE 32: The Incident User Design in Comparative Effectiveness Research (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/incident-user-design_research.pdf
     May 01, 2012 - so poorly—say, every other day—that a prescription intended as a 90-day supply can persist for 180 days … Research Report Number 32 4 example, patients with a known history of NSAID use more than 365 days … Alternatively, patients with a known history of NSAID use more than 365 days before the index date could … For example, patients starting therapy after 365 days without therapy may be at an earlier point in … use.2 Investigators with secondary data sources may find that definitions requiring more than 365 days

151. Case Study Comparing Bayesian and Frequentist Approaches for Multiple Treatment Comparisons (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/indirect-comparisons_research.pdf
     March 01, 2013 - study; treatment with any anti- cholinergic drug or any drug for urinary incontinence within 14 days … with cholinergic or anitcholinergic side effects and participation in a clinical trial within 30 days … intermittent self- catheterization; and electro- stimulation or bladder training within 14 days before … Patients not under OAB therapy could begin treatment after 3-days of baseline diary collection … Patients not under OAB therapy could begin treatment after 3-days of baseline diary collection

152. Comparative Effectiveness and Safety of New Therapies (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-glucose-control_research.pdf
     July 01, 2010 - Thirty percent filled a thiazolidinedione prescription within 60 days of filling exenatide. … pharmacy claims for prescription drugs, including the drug name, prescription fill date and the number of days … construction of the variables indicating use of exenatide and of insulin was as follows: the number of days … insulin product) “on- hand” was calculated using the fill date for the prescription and the number of days … drug-on-hand for 2 Effective Health Care Program Research Report Number 29 more than 50% of the days

153. Making Healthcare Safer IV_Rapid Response: Reducing Adverse Drug Events Related to Anticoagulant Use in Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-high-risk-drugs-rapid-response.pdf
     January 01, 2024 - of discharge, and a followup call by an anticoagulation expert 8–30 days later) or no reminders. … There was no statistically significant change in the time in therapeutic range (percentage of days INR … after discharge, and a follow-up call by an anticoagulation expert 8-30 days later Comparator … Two pharmacist follow-up telephone calls at 30 and 90 days after discharge, for reinforcement … (by 400-780 euros, average difference of 1.5 hospital days).

154. Evidence Summary for CER 239: Acute Treatments for Episodic Migraine (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-239-acute-migraine-evidence-summary.pdf
     December 01, 2020 - Evidence Summary for CER 239: Acute Treatments for Episodic Migraine Comparative Effectiveness Review Number 239 Acute Treatments for Episodic Migraine Evidence Summary Main Points • Compared with placebo, treatments such as triptans, NSAIDs (nonsteroidal anti- inflammatory drugs), dihydroergotamine, antieme…

155. Disposition of Comments for Screening of Methicillin-Resistant Staphylococcus Aureus (MRSA) (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/mrsa-screening-2010_disposition-comments.pdf
     January 01, 2010 - ) and longer turnaround (greater than 2 days). … days (Peterson, 2010). … In fact, for patients who were MRSA-positive the average delay was 5.6 days. … for MRSA-positive patients and ~6 days for VRE-positive patients. … As a result, for patients with ICU length of stay of > 3 days, 59% of ICU days occurred before the results

156. Making Healthcare Safer IV Rapid Review: Engaging Family Caregivers With Structured Communication for Safe Care Transitions (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/engaging-caregivers-rapid-review.pdf
     April 01, 2024 - The study analyzed effects of the intervention on symptom exacerbation (i.e., proportion of days using … ), 1 long- term facility (mean stay 30 to 45 days) Substance misuse A. … drank alcohol • Days used cannabis • Days used any substance • Substance- related problems … B Proportion days drank alcohol (Time x Condition) RR 0.89 (95% CI 0.65 to 1.23) Proportion days … using alcohol, days using cannabis, days using any substance, or substance-related problems.

157. App-F1-Surv-Report-3-Nonopioid-Pharmacol-Chronic-Pain (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/app-f1-surv-report-3-nonopioid-pharmacol-chronic-pain.xlsx
     May 29, 2025 - NPP_Pain Table F-1a. Pain severity for neuropathic pain Author, Year Quality Pain Population Drug Class 1 Drug Class 2 Drug 1 Drug 2 Measure Name Measure Scale Assessment Time (Wk) Time Category Grp 1 Baseline N Grp 1 Baseline Mean Pain Score Grp1 Baseline Variance Type Grp1 Baseline Variance Grp1 Baseline Lower Limi…

158. Systematic Review on Treatments for Acute Pain: Surveillance Report 3 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/main-apps-surv-report-3-acute-pain.pdf
     June 01, 2022 - on 1 RCT) One RCT (n=100)12 identified for Surveillance Report 1 found continuous cooling for 7 days … Tapentadol vs oxycodone for postoperative pain treatment the first 7 days after total knee arthroplasty … Tapentadol vs oxycodone for postoperative pain treatment the first 7 days after total knee arthroplasty … The effect of crizanlizumab on the number of days requiring opioid use for management of pain associated

159. Alcohol-Misuse Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/alcohol-misuse_executive.pdf
     April 28, 2010 - , or changes in other long-term (6 months or longer) outcomes (e.g., health care utilization, sick days … (0.3, 1.5) from ~6.2 days per month at baseline Moderate SOEc Insufficient SOE Pregnant women Data … Insufficient Utilization Hospitalization Fewer hospital days in last 6 months for intervention group … Note: Evidence was insufficient to draw conclusions for sick days or employment stability. … Note: Evidence was insufficient to draw conclusions for sick days, legal issues, employment stability

160. Layout 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ischemic-stroke-treatment_executive.pdf
     January 01, 2011 - the majority of prospective and retrospective studies reporting effectiveness outcomes were either 30 days … or 90 days post-procedure. … NIHSS evaluation was more variable with the longest duration of followup ranging from 24-hours to 90-days … of followup ranged from 6 weeks to 24 months; the most commonly reported length of followup was 90 days